Ipsilateral silent period: A marker of callosal conduction abnormality in early relapsing-remitting multiple sclerosis?

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 133-139

  Jung, Patrick ^a   Beyerle, Astrid ^a   Humpich, Marek ^a   Neumann Haefelin, Tobias ^a   Lanfermann, Heinrich ^a   Ziemann, Ulf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Central motor conduction time; Corpus callosum; Ipsilateral silent period; Relapsing remitting multiple sclerosis; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HAND MUSCLE; HUMAN; MALE; MOTOR NERVE CONDUCTION; MULTIPLE SCLEROSIS; NERVE CONDUCTION DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRAMIDAL TRACT; RECURRENT DISEASE; REMISSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TIBIALIS ANTERIOR MUSCLE;

ADULT; CORPUS CALLOSUM; DISEASE PROGRESSION; EARLY DIAGNOSIS; ELECTRODIAGNOSIS; FEMALE; HAND; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR CORTEX; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUSCLE, SKELETAL; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; PYRAMIDAL TRACTS; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33750522790     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.08.008     Document Type: Article

References (41)

1. Jung P., and Ziemann U. Differences of the ipsilateral silent period in small hand muscles. Muscle Nerve 34 (2006) 431-436
2. Dietemann J.L., Beigelman C., Rumbach L., Vouge M., Tajahmady T., Faubert C., et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology 30 (1988) 478-480
3. Gean-Marton A.D., Vezina L.G., Marton K.I., Stimac G.K., Peyster R.G., Taveras J.M., et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 180 (1991) 215-221
4. Simon J.H., Holtas S.L., Schiffer R.B., Rudick R.A., Herndon R.M., Kido D.K., et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology 160 (1986) 363-367
5. Evangelou N., Esiri M.M., Smith S., Palace J., and Matthews P.M. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47 (2000) 391-395
6. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., and Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125 (2002) 327-337
7. De Stefano N., Narayanan S., Francis G.S., Arnaoutelis R., Tartaglia M.C., Antel J.P., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 (2001) 65-70
8. Pelletier J., Suchet L., Witjas T., Habib M., Guttmann C.R., Salamon G., et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58 (2001) 105-111
9. Barkhof F.J., Elton M., Lindeboom J., Tas M.W., Schmidt W.F., Hommes O.R., et al. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J Neurol 245 (1998) 153-158
10. Lindeboom J., and ter Horst R. Interhemispheric disconnection effects in multiple sclerosis. J Neurol Neurosurg Psychiatry 51 (1988) 1445-1447
11. Pelletier J., Habib M., Lyon-Caen O., Salamon G., Poncet M., and Khalil R. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol 50 (1993) 1077-1082
12. Boroojerdi B., Hungs M., Mull M., Topper R., and Noth J. Interhemispheric inhibition in patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol 109 (1998) 230-237
13. Höppner J., Kunesch E., Buchmann J., Hess A., Grossmann A., and Benecke R. Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis. Clin Neurophysiol 110 (1999) 748-756
14. Schmierer K., Niehaus L., Röricht S., and Meyer B.U. Conduction deficits of callosal fibres in early multiple sclerosis. J Neurol Neurosurg Psychiatry 68 (2000) 633-638
15. Schmierer K., Irlbacher K., Grosse P., Roricht S., and Meyer B.U. Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation. Neurology 59 (2002) 1218-1224
16. Wassermann E.M., Fuhr P., Cohen L.G., and Hallett M. Effects of transcranial magnetic stimulation on ipsilateral muscles. Neurology 41 (1991) 1795-1799
17. Meyer B.U., Röricht S., Gräfin von Einsiedel H., Kruggel F., and Weindl A. Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum. Brain 118 (1995) 429-440
18. Meyer B.-U., Röricht S., and Woiciechowsky C. Topography of fibers in the human corpus callosum mediating interhemispheric inhibition between the motor cortices. Ann Neurol 43 (1998) 360-369
19. Hess C.W., Mills K.R., Murray N.M., and Schriefer T.N. Magnetic brain stimulation: central motor conduction studies in multiple sclerosis. Ann Neurol 22 (1987) 744-752
20. Jones S.M., Streletz L.J., Raab V.E., Knobler R.L., and Lublin F.D. Lower extremity motor evoked potentials in multiple sclerosis. Arch Neurol 48 (1991) 944-948
21. Mayr N., Baumgartner C., Zeitlhofer J., and Deecke L. The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology 41 (1991) 566-569
22. Ravnborg M., Liguori R., Christiansen P., Larsson H., and Sorensen P.S. The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 42 (1992) 1296-1301
23. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
24. Rieckmann P., and Toyka K.V. Escalating immunotherapy of multiple sclerosis. New aspects and practical application. J Neurol 251 (2004) 1329-1339
25. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
26. Wassermann E.M., Pascual-Leone A., and Hallett M. Cortical motor representation of the ipsilateral hand and arm. Exp Brain Res 100 (1994) 121-132
27. Rossini P.M., Berardelli A., Deuschl G., Hallett M., Maertens de Noordhout A.M., Paulus W., et al. Applications of magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol, Suppl 52 (1999) 171-185
28. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 112 Pt 3 (1989) 799-835
29. Ranjeva J.P., Audoin B., Au Duong M.V., Ibarrola D., Confort-Gouny S., Malikova I., et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 26 (2005) 119-127
30. Pagani E., Rocca M.A., Gallo A., Rovaris M., Martinelli V., Comi G., et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 26 (2005) 341-346
31. Garvey M.A., Ziemann U., Becker D.A., Barker C.A., and Bartko J.J. New graphical method to measure silent periods evoked by transcranial magnetic stimulation. Clin Neurophysiol 112 (2001) 1451-1460
32. Claus D. Central motor conduction: method and normal results. Muscle Nerve 13 (1990) 1125-1132
33. O'Connor P., Marchetti P., Lee L., and Perera M. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis. Ann Neurol 44 (1998) 404-407
34. Fuhr P., Borggrefe-Chappuis A., Schindler C., and Kappos L. Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124 (2001) 2162-2168
35. Miller D.H., Grossman R.I., Reingold S.C., and McFarland H.F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121 (1998) 3-24
36. Wahl M., Lauterbach-Soon B., Hattingen E., Ogrezeanu G., Lanfermann H., and Ziemann U. Determining the topography of interhemispheric fibres in the human corpus callosum (CC) between the primary motor cortices with a combined fMRI/DTI-fibretracking prodecure [Abstract]. Klin Neurophysiol 37 (2006) 96-97
37. Gould H.J.D., Cusick C.G., Pons T.P., and Kaas J.H. The relationship of corpus callosum connections to electrical stimulation maps of motor, supplementary motor, and the frontal eye fields in owl monkeys. J Comp Neurol 247 (1986) 297-325
38. Rouiller E.M., Babalian A., Kazennikov O., Moret V., Yu X.H., and Wiesendanger M. Transcallosal connections of the distal forelimb representations of the primary and supplementary motor cortical areas in macaque monkeys. Exp Brain Res 102 (1994) 227-243
39. Aboitiz F., Scheibel A.B., Fisher R.S., and Zaidel E. Fiber composition of the human corpus callosum. Brain Res 598 (1992) 143-153
40. Röricht S., Meyer B.-U., Woichiechowsky C., and Lehmann R. Callosal and corticospinal tract function in patients with hydrocephalus: a morphometric and transcranial magnetic stimulation study. J Neurol 245 (1998) 280-288
41. Wolters A., Classen J., Kunesch E., Grossmann A., and Benecke R. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Mov Disord 19 (2004) 518-528